NCT06659250View on ClinicalTrials.gov

A Study to Learn How Different Amounts and Forms of the Study Medicine Called PF-06414300 Act in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

September 27, 2024

Primary Completion Date

August 22, 2025

Study Completion Date

August 22, 2025

Conditions
Healthy Participants
Interventions
DRUG

PF-06414300

Participants will receive oral ascending doses.

DRUG

Placebo

Participants will receive matching placebo.

Trial Locations (1)

06511

Pfizer Clinical Research Unit - New Haven, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06659250 - A Study to Learn How Different Amounts and Forms of the Study Medicine Called PF-06414300 Act in Healthy Adults | Biotech Hunter | Biotech Hunter